Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

Alexander D. Boiko (), Olga V. Razorenova, Matt van de Rijn, Susan M. Swetter, Denise L. Johnson, Daphne P. Ly, Paris D. Butler, George P. Yang, Benzion Joshua, Michael J. Kaplan, Michael T. Longaker and Irving L. Weissman ()
Additional contact information
Alexander D. Boiko: Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94304-5542, USA
Olga V. Razorenova: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Matt van de Rijn: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Susan M. Swetter: Pigmented Lesion and Melanoma Program, Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Denise L. Johnson: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Daphne P. Ly: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Paris D. Butler: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
George P. Yang: Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA
Benzion Joshua: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Michael J. Kaplan: Stanford University Medical Center, Stanford Cancer Center, Stanford, California 94305-5118, USA
Michael T. Longaker: Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94304-5542, USA
Irving L. Weissman: Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94304-5542, USA

Nature, 2010, vol. 466, issue 7302, 133-137

Abstract: A marker for cancer stem cells A number of studies have reported the existence of cancer stem cells in human melanomas, each one capable of producing a tumour. Boiko et al. examined a broad spectrum of clinical samples taken from melanomas and report that the neural crest stem-cell marker CD271 is a marker for cancer stem cells, allowing the identification and prospective isolation of melanoma cancer stem cells.

Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/nature09161 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:466:y:2010:i:7302:d:10.1038_nature09161

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature09161

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().